Weston Whitaker is a co-founder of Novome Biotechnologies, a South San Francisco startup founded in 2016 based on technology developed by the founders in Justin Sonnenburg’s lab at Stanford University. Novome is developing commensal gut microbes that have been engineered to predictably colonize the gut and robustly deliver specific therapeutic activities.
Weston Whitaker received his B.S. in Biomedical Engineering from Columbia University. He received his Ph.D. in Bioengineering from University of California, Berkeley studying synthetic biology in the labs of Dr. Adam Arkin and Dr. John Dueber. He completed his post-doctoral fellowship in Justin Sonnenburg’s lab at Stanford University, where he developed genetic tools for Bacteroides, the most common gut bacteria genus.